Policy Views
Discover our articles
Posted on 25.02.2021
The impact of the pandemic on people living with rare diseases
By Sandra Courbier, Social Research Director - Rare Barometer Programme Lead
Posted on 02.02.2021
Biobanks and medtech: an underdeveloped partnership
By Francesco Florindi, Strategy & Partnership Manager, BBMRI-ERIC
Posted on 28.01.2021
Answering the Call of Telehealth
By Sorin Stircu, Regional MedTech Strategist at E*HealthLine - Europe Global Office
Posted on 10.12.2020
Accelerating medtech innovation in paediatrics
By Kolaleh Eskandanian, Vice President and Chief Innovation Officer at Children’s National Hospital
Posted on 26.11.2020
In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations
By Natale Bova, Chair of the Regulatory IVD Forum of Confindustria Dispositivi Medici
Posted on 03.11.2020
Current trends in tendering innovation at risk
By Slobodan Farago, Pricing and Sales Force Effectiveness Manager MDS Europe BD
Posted on 30.10.2020
Planning ahead – with clear data
By Kathleen Van Vlierberghe, Senior Director, Healthcare Solutions and Partnerships, EMEA at Boston Scientific
Posted on 26.10.2020
COPD & COVID-19: Pandemic must prompt shift to connected care
By Odile Bigaignon, Vice President, EMEA Marketing at ResMed
Posted on 26.10.2020
The implications of COVID-19 on recruiting in the Life Science sector
By Noel Brown, Global Head of Talent Attraction & Acquisition at Thermo Fisher Scientific
Posted on 20.10.2020
In crisis, medtech found the path to realise its full potential
By Eric Thépaut, Senior Vice President and President, EMEA - Boston Scientific
Posted on 29.09.2020
Your heart has never been more important
By Jean-Luc Lemercier, Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe
Posted on 21.09.2020
EU Health PPP: a new era for medtech companies
By Philippe Cleuziat, Senior Director, R&D Department Open Innovation & Partnerships at bioMerieux

